Solid Biosciences Financials - Benzinga

Solid Biosciences Inc

SLDBNASDAQ

Trade with Public

Trade with Public

$8.71

-0.02-0.23%

At close: Aug 6, 5:00 PM EST

$8.25

-0.46-5.28%

After Hours: 6:04 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Solid Biosciences Financials

Solid Biosciences (SLDB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Solid Biosciences Q2 EPS $(0.38) Beats $(0.46) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 9.52 percent increase over losses of $(0.42) per share from

Benzinga Newsdesk

PRO
Solid Biosciences Q1 EPS $(0.52) Misses $(0.44) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.44) by 18.18 percent. This is a 11.86 percent increase over losses of $(0.59) per share

Benzinga Newsdesk

PRO
Solid Biosciences Q4 EPS $(0.53) Misses $(0.50) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.50) by 5.79 percent. This is a 47 percent increase over losses of $(1.00) per share from

Benzinga Newsdesk

PRO
Solid Biosciences Q3 EPS $(0.48) Misses $(0.43) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.43) by 11.11 percent. This is a 39.24 percent increase over losses of $(0.79) per share

Benzinga Newsdesk

PRO
Solid Biosciences Q2 EPS $(0.42) Beats $(0.53) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.53) by 20 percent. This is a 31.15 percent increase over losses of $(0.61) per share from

Benzinga Newsdesk

PRO
Solid Biosciences Q1 EPS $(0.59) Misses $(0.56) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 7.81 percent increase over losses of $(0.64) per share from

Benzinga Newsdesk